Neumora Therapeutics, Inc. (NASDAQ:NMRA - Free Report) - Analysts at William Blair boosted their Q3 ...
Neumora Therapeutics, Inc. (NASDAQ:NMRA - Free Report) - Analysts at HC Wainwright increased their Q...
Neumora Therapeutics, Inc. (NASDAQ:NMRA - Free Report) - Stock analysts at William Blair raised thei...
Sarepta reported a quarter-on-quarter dip in sales for its Duchenne gene therapy. Elsewhere, Jazz wo...